Journal of Clinical Pediatrics >
Beware of the pitfalls in diagnosis and treatment of autoimmune encephalitis in children
Received date: 2022-11-29
Online published: 2023-09-05
Over the past 15 years, the development of antibody detection technology led to the increased awareness of autoimmune encephalitis. However, the innovation has also brought about a certain proportion of misdiagnosis, and some patients have been treated improperly as a result. The main reasons for misdiagnosis include lax implementation of diagnostic criteria, incorrect interpretation of antibody test results, and insufficient differential diagnosis. Compared with adults, the symptoms of children with autoimmune encephalitis are more difficult to identify, and there are antibody spectrum and characteristics that are different from those of adults. The differential diagnosis of the disease involves a wider range, and its diagnosis and treatment face greater challenges. This article will summarize the diagnosis and treatment process of autoimmune encephalitis in children based on the current situation in China. The related pitfalls of diagnosis and treatment are interpreted and analyzed in order to help pediatricians improve accurate diagnosis and treatment of autoimmune encephalitis.
Key words： autoimmune encephalitis; diagnosis; therapy; child
Weihua ZHANG , Liping ZOU , Haitao REN , Hongzhi GUAN . Beware of the pitfalls in diagnosis and treatment of autoimmune encephalitis in children[J]. Journal of Clinical Pediatrics, 2023 , 41(9) : 644 -649 . DOI: 10.12372/jcp.2023.23e0455
| [1] | Dalmau J, Graus F. Antibody-mediated encephalitis[J]. N Engl J Med, 2018, 378(9): 840-851. |
| [2] | Dalmau J, Graus F. Autoimmune Encephalitis-misdiagnosis, misconceptions, and how to avoid them[J]. JAMA Neurol, 2023, 80(1): 12-14. |
| [3] | Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, et al. Autoimmune encephalitis misdiagnosis in adults[J]. JAMA Neurol, 2023, 80(1): 30-39. |
| [4] | Cellucci T, Van Mater H, Graus F, et al. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(2): e663. |
| [5] | 中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 中国自身免疫性脑炎诊治专家共识(2022年版)[J]. 中华神经科杂志, 2022, 55(9): 931-949. |
| [6] | Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis[J]. Lancet Neurol, 2018, 17(9): 760-772. |
| [7] | Hara M, Martinez-Hernandez E, Ari?o H, et al. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor[J]. Neurology, 2018, 90(16): e1386-e1394. |
| [8] | Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study[J]. Lancet Neurol, 2014, 13(2): 167-177. |
| [9] | Blincoe A, Heeg M, Campbell PK, et al. Neuro-inflammatory disease as an isolated manifestation of hemophagocytic lymphohistiocytosis[J]. J Clin Immunol, 2020, 40(6): 901-916. |
| [10] | Livingston JH, Crow YJ. Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières syndrome and beyond[J]. Neuropediatrics, 2016, 47(6): 355-360. |
| [11] | Simons A, Eyskens F, Glazemakers I, et al. Can psychiatric childhood disorders be due to inborn errors of metabolism?[J]. Eur Child Adolesc Psychiatry, 2017, 26(2): 143-154. |
| [12] | Zhang W, Li J, Zhuo X, et al. Chinese patients with p.Arg756 mutations of ATP1A3: clinical manifestations, treatment, and follow-up[J]. Pediatr Investig, 2022, 6(1): 5-10. |
| [13] | Nosadini M, Thomas T, Eyre M, et al. International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis[J]. Neurol Neuroimmunol Neuroinflamm, 2021, 8(5): e1052. |
| [14] | Zhang W, Ren C, Wang X, et al. Age-dependent characteristics and prognostic factors of pediatric anti-N-methyl-d-aspartate receptor encephalitis in a Chinese single-center study[J]. Eur J Paediatr Neurol, 2021, 34: 67-73. |
| [15] | Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J]. Lancet Neurol, 2013, 12(2): 157-165. |
| [16] | Lee WJ, Lee ST, Byun JI, et al. Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort[J]. Neurology, 2016, 86(18): 1683-1691. |
| [17] | Lim JA, Lee ST, Moon J, et al. Development of the clinical assessment scale in autoimmune encephalitis[J]. Ann Neurol, 2019, 85(3): 352-358. |
| [18] | Du Y, Zhao C, Liu J, et al. Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies[J]. J Neuroinflammation, 2022, 19(1): 259. |
| [19] | Lee WJ, Lee ST, Moon J, et al. Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study[J]. Neurotherapeutics, 2016, 13(4): 824-832. |
| [20] | Randell RL, Adams AV, Van Mater H. Tocilizumab in refractory autoimmune encephalitis: a series of pediatric cases[J]. Pediatr Neurol, 2018, 86: 66-68. |
| [21] | Tatencloux S, Chretien P, Rogemond V, et al. Intrathecal treatment of anti-N-Methyl-D-aspartate receptor encephalitis in children[J]. Dev Med Child Neurol, 2015, 57(1): 95-99. |
| [22] | Spiegel R, Miron D, Yodko H, et al. Late relapse of herpes simplex virus encephalitis in a child due to reactivation of latent virus: clinicopathological report and review[J]. J Child Neurol, 2008, 23(3): 344-348. |
/
| 〈 |
|
〉 |
